Award

NIH Reporter #1R43CA298411-01A1

Functional signatures of post-infusion CAR T cells for early indication of patient response

Recipient

CELLCHORUS INC.

Award Amount

$399,625.00

Ceiling

$399,625.00

Awarded

August 21, 2025

Identifier

1R43CA298411-01A1

NIH-funded project to develop predictive signatures for CAR T cell therapy response using advanced live-cell imaging and AI analysis.

Description

This project aims to develop a functional signature associated with patient response to CAR T cell therapy in relapsed/refractory large B cell lymphoma (r/rLBCL). Using Time-lapse Imaging Microscopy In Nanowell Grids (TIMING™), the study will profile post-infusion CAR-T cells to identify early predictors of treatment response, facilitating better treatment planning and response assessment.

View original record